The single-cell analysis market is expected to grow from US$ 3.18 billion in 2021 to US$ 8.20 billion by 2028; it is projected to grow at a CAGR of 14.5% from 2022 to 2028.
Single-cell analysis allows for in-depth analysis of stem cell differentiation, cancer, and physiological functions in embryos and adults. Advanced technologies such as single-cell sequencing technologies, in situ hybridization, fluorescence-based detection, and mass spectroscopy can be used to study diseases and drug development, owing to which the market for single-cell analysis is expected to grow exponentially.
MARKET DYNAMICS
The single-cell analysis market growth is majorly attributed to increasing R&D in the pharmaceutical and biotechnology industries, rising number of cancer cases, technological advancements, and growing demand for personalized medicine. Moreover, rapid progress in cancer research and strategic collaboration among major players are expected to fuel the single-cell analysis market during the forecast period. However, high costs and a dearth of skilled professionals are factors hampering the growth of the market.
MARKET SCOPE
The “Global Single-Cell Analysis Market Analysis to 2028” report aims to provide an overview of the market with detailed segmentation based on product, cell type, technique, application, and end user. The report provides key market statistics based on the performance of leading players. It also offers key trends and opportunities in the market.
Strategic Insights
MARKET SEGMENTATION
The global single-cell analysis market is segmented into product, cell type, technique, application, and end user. Based on product, the market is bifurcated into consumables and instruments. By cell type, the market is segmented into human cells, animal cells, and microbial cells. In terms of technique, the market Is categorized into flow cytometry, next-generation sequencing, polymerase chain reaction, microscopy, mass spectrometry, and other techniques. From application point of reference, the market is bifurcated into research applications and medical applications. The end user segment is further segmented into academic and research laboratories, biotechnology and pharmaceutical companies, hospitals and diagnostic laboratories, and cell banks and IVF centers.
REGIONAL FRAMEWORK
The global single-cell analysis market is segmented into five major regions—North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The report covers analysis and forecast of 18 countries along with trends and opportunities prevailing in the region.
From the regional perspective, North America dominated the single-cell analysis market with ~42% market share in 2021. The market growth in the region is majorly attributed to increasing R&D expenditure and government funding, growing pharmaceutical and life science industry, and strategic initiatives by prominent players along with the existence of major players in the region. For instance, in January 2022, Amgen entered into a partnership with Generate Biomedicines to discover and create protein therapeutics for five targets across various therapeutic areas and multiple functionality with billion dollars investment. Additionally, the high incidence of chronic diseases such as cancers in the region is driving the market growth. The below figure showcases the revenue growth trend in the global single-cell analysis market:
Source: The Insight Partners Analysis
The report analyzes factors, such as drivers, restraints, opportunities, and future trends, affecting the single-cell analysis market. It also provides an exhaustive Porter's five forces analysis of the single-cell analysis market.
IMPACT OF COVID-19 PANDEMIC
The single-cell analysis aids in the interpretation of peripheral immune response to COVID-19 infection and contributes to new approaches for research into the disease's mechanisms and treatment options resulting in the increased adoption of single-cell analysis products for COVID-19 research. Therefore, the increased product demand and ongoing research activities are expected to create market growth opportunities. Although various government decisions due to pandemic economic conditions restricted the overall production, the single-cell analysis products witnessed burgeoning demand for vaccine development and production across the world. Thus, single-cell analysis market was positively impacted during the COVID-19 pandemic.
MARKET PLAYERS
The report covers key developments in the single-cell analysis market. Various companies are focusing on organic growth strategies, such as product launches, product approvals, patents, and events. Inorganic growth strategies such as acquisitions, partnerships, and collaborations have encouraged the expansion of business and the customer base of market players. The market players operating in the single-cell analysis market are anticipated to experience lucrative growth opportunities in the coming years with the rising demand for single-cell analysis products.
The report also includes the profiles of key single-cell analysis market companies, along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information for the last three years, and key development in the past five years. The list of a few companies engaged in the single-cell analysis market is mentioned below:
- Agilent Technologies
- Beckman Coulter Inc.
- Becton Dickinson & Company (BD)
- Bio-Rad Laboratories, Inc.
- Fluidigm Corporation
- GE Healthcare
- Illumina, Inc.
- Merck KGaA
- Qiagen N.V.
- Thermo Fisher Scientific, Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS